Cargando…
Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890619/ https://www.ncbi.nlm.nih.gov/pubmed/33596911 http://dx.doi.org/10.1186/s12934-021-01522-5 |
_version_ | 1783652540156477440 |
---|---|
author | Pikl, Špela Rincón, Andrés Felipe Carrillo Slemc, Lucija Goranovič, Dušan Avbelj, Martina Gjuračić, Krešimir Sucipto, Hilda Stare, Katja Baebler, Špela Šala, Martin Guo, Meijin Luzhetskyy, Andriy Petković, Hrvoje Magdevska, Vasilka |
author_facet | Pikl, Špela Rincón, Andrés Felipe Carrillo Slemc, Lucija Goranovič, Dušan Avbelj, Martina Gjuračić, Krešimir Sucipto, Hilda Stare, Katja Baebler, Špela Šala, Martin Guo, Meijin Luzhetskyy, Andriy Petković, Hrvoje Magdevska, Vasilka |
author_sort | Pikl, Špela |
collection | PubMed |
description | BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds for commercial production. Although great efforts have been invested in strain selection methods, many of these technologies have not been improved in decades, which might pose a serious threat to the economic and industrial viability of such important bioprocesses. RESULTS: In recent years, introduction of extra copies of an entire biosynthetic pathway that encodes a target product in a single microbial host has become a technically feasible approach. However, this often results in minor to moderate increases in target titers. Strain stability and process reproducibility are the other critical factors in the industrial setting. Industrial Streptomyces rimosus strains for production of oxytetracycline are one of the most economically efficient strains ever developed, and thus these represent a very good industrial case. To evaluate the applicability of amplification of an entire gene cluster in a single host strain, we developed and evaluated various gene tools to introduce multiple copies of the entire oxytetracycline gene cluster into three different Streptomyces rimosus strains: wild-type, and medium and high oxytetracycline-producing strains. We evaluated the production levels of these engineered S. rimosus strains with extra copies of the oxytetracycline gene cluster and their stability, and the oxytetracycline gene cluster expression profiles; we also identified the chromosomal integration sites. CONCLUSIONS: This study shows that stable and reproducible increases in target secondary metabolite titers can be achieved in wild-type and in high oxytetracycline-producing strains, which always reflects the metabolic background of each independent S. rimosus strain. Although this approach is technically very demanding and requires systematic effort, when combined with modern strain selection methods, it might constitute a very valuable approach in industrial process development. |
format | Online Article Text |
id | pubmed-7890619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78906192021-02-22 Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers Pikl, Špela Rincón, Andrés Felipe Carrillo Slemc, Lucija Goranovič, Dušan Avbelj, Martina Gjuračić, Krešimir Sucipto, Hilda Stare, Katja Baebler, Špela Šala, Martin Guo, Meijin Luzhetskyy, Andriy Petković, Hrvoje Magdevska, Vasilka Microb Cell Fact Research BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds for commercial production. Although great efforts have been invested in strain selection methods, many of these technologies have not been improved in decades, which might pose a serious threat to the economic and industrial viability of such important bioprocesses. RESULTS: In recent years, introduction of extra copies of an entire biosynthetic pathway that encodes a target product in a single microbial host has become a technically feasible approach. However, this often results in minor to moderate increases in target titers. Strain stability and process reproducibility are the other critical factors in the industrial setting. Industrial Streptomyces rimosus strains for production of oxytetracycline are one of the most economically efficient strains ever developed, and thus these represent a very good industrial case. To evaluate the applicability of amplification of an entire gene cluster in a single host strain, we developed and evaluated various gene tools to introduce multiple copies of the entire oxytetracycline gene cluster into three different Streptomyces rimosus strains: wild-type, and medium and high oxytetracycline-producing strains. We evaluated the production levels of these engineered S. rimosus strains with extra copies of the oxytetracycline gene cluster and their stability, and the oxytetracycline gene cluster expression profiles; we also identified the chromosomal integration sites. CONCLUSIONS: This study shows that stable and reproducible increases in target secondary metabolite titers can be achieved in wild-type and in high oxytetracycline-producing strains, which always reflects the metabolic background of each independent S. rimosus strain. Although this approach is technically very demanding and requires systematic effort, when combined with modern strain selection methods, it might constitute a very valuable approach in industrial process development. BioMed Central 2021-02-17 /pmc/articles/PMC7890619/ /pubmed/33596911 http://dx.doi.org/10.1186/s12934-021-01522-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Pikl, Špela Rincón, Andrés Felipe Carrillo Slemc, Lucija Goranovič, Dušan Avbelj, Martina Gjuračić, Krešimir Sucipto, Hilda Stare, Katja Baebler, Špela Šala, Martin Guo, Meijin Luzhetskyy, Andriy Petković, Hrvoje Magdevska, Vasilka Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title | Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title_full | Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title_fullStr | Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title_full_unstemmed | Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title_short | Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers |
title_sort | multiple copies of the oxytetracycline gene cluster in selected streptomyces rimosus strains can provide significantly increased titers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890619/ https://www.ncbi.nlm.nih.gov/pubmed/33596911 http://dx.doi.org/10.1186/s12934-021-01522-5 |
work_keys_str_mv | AT piklspela multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT rinconandresfelipecarrillo multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT slemclucija multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT goranovicdusan multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT avbeljmartina multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT gjuracickresimir multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT suciptohilda multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT starekatja multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT baeblerspela multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT salamartin multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT guomeijin multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT luzhetskyyandriy multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT petkovichrvoje multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters AT magdevskavasilka multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters |